{"publication_id":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","content_hash":"sha256:0c1084c49ce0e53d8a2a1644bfdf89ea289bab76cbf2f269a57508166ad3c0fe","nodes":[{"id":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","type":"publication","title":"Glycation aging evidence is a damage-burden signal, not a validated anti-aging intervention"},{"id":"claim_1","type":"claim","text":"The anti-aging conversation often treats glycation as if the mechanism, biomarker, dietary exposure, diabetes complication literature, and intervention claim were one continuous evidence chain. The current source bundle supports a narrower and more useful split: AGEs are repeatedly connected with oxidative stress, metabolic disease, tissue injury, and molecular aging, but that does not automatically promote any intervention to a longevity endpoint claim."},{"id":"claim_2","type":"claim","text":"A diabetes-focused review links AGEs with oxidative stress in type 2 diabetes, supporting metabolic-damage relevance without generalizing to healthy-aging intervention efficacy. DOI `10.3390/biom5010194`."},{"id":"claim_3","type":"claim","text":"A 2019 review connects oxidative stress, advanced lipoxidation products, and AGEs with aging and age-related diseases, supporting the damage-burden framing. DOI `10.1155/2019/3085756`."},{"id":"claim_4","type":"claim","text":"A 2021 review discusses AGEs and related adducts across aging-related diseases and alcohol-mediated tissue injury, again supporting cross-condition mechanism rather than a single geroprotective treatment claim. DOI `10.1038/s12276-021-00561-7`."},{"id":"claim_5","type":"claim","text":"For longevity triage, glycation should be routed into two separate queues: measurement/source-of-damage evidence on one side, and intervention-outcome evidence on the other. The source bundle is strong enough to justify an alpha memo about the boundary, but not strong enough to publish a broad claim that anti-glycation products slow human aging."},{"id":"claim_6","type":"claim","text":"Direct comparative evidence showing AGE biomarkers add little beyond glucose, renal function, inflammation, or oxidative-stress markers would weaken the measurement-lane claim."},{"id":"claim_7","type":"claim","text":"The fresh longevity signal is not \"AGEs are the cause of aging\". The publishable alpha is the boundary: glycation has enough source support to be a serious aging-damage lane, while intervention claims still need direct endpoint receipts before they should be sold as anti-aging evidence."},{"id":"source_1","type":"source","study":"Advanced Glycation End Products in Disease Development and Potential Interventions","year":2025,"doi":"10.3390/antiox14040492","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_2","type":"source","study":"Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus","year":2015,"doi":"10.3390/biom5010194","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_3","type":"source","study":"Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases","year":2019,"doi":"10.1155/2019/3085756","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_4","type":"source","study":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","year":2021,"doi":"10.1038/s12276-021-00561-7","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_5","type":"source","study":"A Role for Advanced Glycation End Products in Molecular Ageing","year":2023,"doi":"10.3390/ijms24129881","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"}],"edges":[{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_1","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_2","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_3","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_4","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_5","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_6","type":"contains_claim"},{"from":"c6d3ba53-9649-4ef6-99a5-715cf01ac662","to":"claim_7","type":"contains_claim"}],"screening":{"identified":5,"screened":5,"excluded":0,"included":5,"included_or_retained":5,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]}}